If you’re a frequent eye drop user, now’s the time to check your medicine cabinet: The pharmaceutical lab BRS Analytical Service, LLC has issued a voluntary recall of five different ophthalmic solutions, including some eye drops and artificial tears, due to concerns that the products may be of “unacceptable quality.” Here’s what to know:

According to a notice published by the distributor AvKare, the recall was initiated when a U.S. Food and Drug Administration (FDA) audit found “manufacturing cGMP deviations” in the production of the five eye products. CGMP, or

© Fast Company